
2D vs 3D breast cancer models: Patient‑derived organoids elevate tumor modeling
3D breast cancer models are rapidly redefining how we investigate the world’s deadliest malignancy in women,
3D breast cancer models are rapidly redefining how we investigate the world’s deadliest malignancy in women,
Breast cancer has long been one of the most prevalent and challenging cancers worldwide, demanding constant
Breast cancer remains the most frequently diagnosed malignancy in women worldwide and a leading cause of
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
Modern drug discovery is shifting from “one-size-fits-all” animal models toward new-approach methodologies (NAMs) that capture human-specific
The interplay between adipose tissue and therapeutic efficacy is now recognised as a major determinant of clinical
Spheroids, as a good universal organ model ? Recent advances in bioengineering of cells, tissue coupled
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023